These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 21860411

  • 21. Purification and assay of the chaperone-dependent ubiquitin ligase of the carboxyl terminus of Hsc70-interacting protein.
    Murata S, Minami M, Minami Y.
    Methods Enzymol; 2005; 398():271-9. PubMed ID: 16275335
    [Abstract] [Full Text] [Related]

  • 22. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
    Smith JR, Workman P.
    Cell Cycle; 2009 Feb 01; 8(3):362-72. PubMed ID: 19177013
    [Abstract] [Full Text] [Related]

  • 23. Cdc37 goes beyond Hsp90 and kinases.
    MacLean M, Picard D.
    Cell Stress Chaperones; 2003 Feb 01; 8(2):114-9. PubMed ID: 14627196
    [Abstract] [Full Text] [Related]

  • 24. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.
    Stepanova L, Leng X, Parker SB, Harper JW.
    Genes Dev; 1996 Jun 15; 10(12):1491-502. PubMed ID: 8666233
    [Abstract] [Full Text] [Related]

  • 25. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM, Scherr MJ, Freiburger L, Daake MA, Sattler M, Richter K.
    J Biol Chem; 2015 Dec 25; 290(52):30843-54. PubMed ID: 26511315
    [Abstract] [Full Text] [Related]

  • 26. Cdc37 is a molecular chaperone with specific functions in signal transduction.
    Kimura Y, Rutherford SL, Miyata Y, Yahara I, Freeman BC, Yue L, Morimoto RI, Lindquist S.
    Genes Dev; 1997 Jul 15; 11(14):1775-85. PubMed ID: 9242486
    [Abstract] [Full Text] [Related]

  • 27. Cdc37 as a Co-chaperone to Hsp90.
    Prince TL, Lang BJ, Okusha Y, Eguchi T, Calderwood SK.
    Subcell Biochem; 2023 Jul 15; 101():141-158. PubMed ID: 36520306
    [Abstract] [Full Text] [Related]

  • 28. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins.
    Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Höhfeld J, Patterson C.
    Nat Cell Biol; 2001 Jan 15; 3(1):93-6. PubMed ID: 11146632
    [Abstract] [Full Text] [Related]

  • 29. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
    Vaughan CK, Mollapour M, Smith JR, Truman A, Hu B, Good VM, Panaretou B, Neckers L, Clarke PA, Workman P, Piper PW, Prodromou C, Pearl LH.
    Mol Cell; 2008 Sep 26; 31(6):886-95. PubMed ID: 18922470
    [Abstract] [Full Text] [Related]

  • 30. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
    Eckl JM, Rutz DA, Haslbeck V, Zierer BK, Reinstein J, Richter K.
    J Biol Chem; 2013 May 31; 288(22):16032-42. PubMed ID: 23569206
    [Abstract] [Full Text] [Related]

  • 31. The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity.
    Xu W, Neckers L.
    Future Oncol; 2012 Aug 31; 8(8):939-42. PubMed ID: 22894668
    [Abstract] [Full Text] [Related]

  • 32. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes.
    Choi JS, Cho S, Park SG, Park BC, Lee DH.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):574-83. PubMed ID: 15358145
    [Abstract] [Full Text] [Related]

  • 33. Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.
    Verma S, Singh A, Mishra A.
    J Mol Graph Model; 2012 Jul 27; 37():27-38. PubMed ID: 22609743
    [Abstract] [Full Text] [Related]

  • 34. Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology.
    Lerner Y, Sukumaran S, Chua MS, So SK, Qvit N.
    J Vis Exp; 2022 Mar 31; (181):. PubMed ID: 35435890
    [Abstract] [Full Text] [Related]

  • 35. Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.
    Sonamoto R, Kii I, Koike Y, Sumida Y, Kato-Sumida T, Okuno Y, Hosoya T, Hagiwara M.
    Sci Rep; 2015 Aug 03; 5():12728. PubMed ID: 26234946
    [Abstract] [Full Text] [Related]

  • 36. Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy.
    Joo JH, Dorsey FC, Joshi A, Hennessy-Walters KM, Rose KL, McCastlain K, Zhang J, Iyengar R, Jung CH, Suen DF, Steeves MA, Yang CY, Prater SM, Kim DH, Thompson CB, Youle RJ, Ney PA, Cleveland JL, Kundu M.
    Mol Cell; 2011 Aug 19; 43(4):572-85. PubMed ID: 21855797
    [Abstract] [Full Text] [Related]

  • 37. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM, Kretzschmar A, Richter K.
    J Biol Chem; 2010 Dec 24; 285(52):40921-32. PubMed ID: 20880838
    [Abstract] [Full Text] [Related]

  • 38. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
    Keramisanou D, Aboalroub A, Zhang Z, Liu W, Marshall D, Diviney A, Larsen RW, Landgraf R, Gelis I.
    Mol Cell; 2016 Apr 21; 62(2):260-271. PubMed ID: 27105117
    [Abstract] [Full Text] [Related]

  • 39. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
    Prince T, Sun L, Matts RL.
    Biochemistry; 2005 Nov 22; 44(46):15287-95. PubMed ID: 16285732
    [Abstract] [Full Text] [Related]

  • 40. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
    Zhang H, Wu W, Du Y, Santos SJ, Conrad SE, Watson JT, Grammatikakis N, Gallo KA.
    J Biol Chem; 2004 May 07; 279(19):19457-63. PubMed ID: 15001580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.